| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 120,545 | 116,183 | 109,141 | 121,177 | | Cost of Revenue | 38,280 | 33,314 | 32,202 | 30,681 | | | Gross Profit | 82,265 | 82,869 | 76,939 | 90,496 | | | Operating Expenses | | Research Development | 26,069 | 24,998 | 24,158 | 24,507 | | Selling General and Administrative | 31,839 | 24,901 | 25,586 | 23,617 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,114 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 23,243 | 32,970 | 27,195 | 42,372 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,227 | 4,740 | 3,841 | 2,238 | | Earnings Before Interest And Taxes | 32,470 | 37,710 | 31,036 | 44,610 | | Interest Expense | 726 | 151 | (3) | 1 | | Income Before Tax | 31,744 | 37,559 | 31,039 | 44,609 | | Income Tax Expense | 11,929 | 11,812 | 9,899 | 15,531 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 19,815 | 25,747 | 21,140 | 29,078 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 19,815 | 25,747 | 21,140 | 29,078 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $19,815 | $25,747 | $21,140 | $29,078 |
|
0.17% Nasdaq 0.00%
Income Statement
